Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
16 Feb, 2021 | 02:15h | UTC
Commentaries on Twitter
Our @TheLancet #COVID19 Commission/TF publication. 1- More funds to COVAX urgently needed 2- Support members of DCVMN to produce low-cost vaccines at scale 3- Support waiver of TRIPS to facilitate rapid scale-up of production and distribution @PeterHotezhttps://t.co/E8tYj69MBG
— Maria Elena Bottazzi (@mebottazzi) February 13, 2021
“The Lancet COVID-19 Commission supports the emergency waiver of TRIPS in all circumstances that would facilitate the rapid scale-up of production and distribution of life-saving COVID-19 vaccines and therapeutics..”https://t.co/e5FBqY9r2R
— Tahir Amin (@realtahiramin) February 14, 2021